WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday. The facility, with a net ...

The Dundalk site will become part of the company’s network of five, large-scale pharma manufacturing sites China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD ...

Alternatively, you can pay €0.50 per article, capped at €1 per day. WuXi Biologics will hold career information open days in hotels in both Dundalk and Drogheda for its new Dundalk facility over the ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

The employees at WuXi Biologics have once again shown their commitment to the local community with their fourth annual Christmas appeal for the St. Vincent de Paul Society in Dundalk. Continuing ...

Since becoming operational in March 2022, WuXi Biologics Ireland site that began as greenfield development in Dundalk has rapidly established itself as a leader in advanced biomanufacturing.

The Dundalk site provides drug substance and product manufacturing, as well as quality control capabilities. Credit: Comezora via Getty Images. WuXi Biologics subsidiary WuXi Vaccines has agreed to ...

DUNDALK, Ireland, Dec. 5, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced major ...